Cortisol and dehydroepiandosterone sulfate plasma levels and their relationship to aging, cognitive function, and dementia

Brain and Cognition

Volumn 50, Issue 2, 2002, Pages 316-323

  De Bruin, V M S ^a   Vieira, M C M ^a   Rocha, M N M ^a   Viana, G S B ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Alzheimer; Cognition; Cortisol; Cortisol DHEAS ratio; Dementia; Depression; DHEAS; Minimental; Nervous system; Steroid

Indexed keywords

HYDROCORTISONE; IODINE 125; PRASTERONE;

ADULT; AGED; AGING; ARTICLE; BLOOD SAMPLING; COGNITION; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEMENTIA; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; BRAIN; COGNITION DISORDERS; DEHYDROEPIANDROSTERONE SULFATE; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED;

EID: 0036924873     PISSN: 02782626     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-2626(02)00519-5     Document Type: Article

References (44)

1. Aragno, M., Tamagno, E., Gatto, V., Brignar dello, E., Parola, S., Danni, S., & Boccuzzi, G. (1999). Dehydroepiandrosterone protects tissues of streptozocin-treated rats against oxidative stress. Free Radical Biology and Medicine, 26, 1467-1474.
2. Barrett-Connor, E., & Ferrara, A. (1996). Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: The Rancho Bernardo Study. Journal of Clinical Endocrinology and Metabolism, 81, 59-64.
3. Barrett-Connor, E., Khaw, K.-T., & Yen, S. S. C. (1986). A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease. New England Journal of Medicine, 315, 1519-1524.
4. Barrett-Connor, E., Von Muhlen, D., Laughlin, G., & Kripke, A. (1999). Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: The Rancho Bernardo Study. Journal of the American Geriatrics Society, 47, 685-691.
5. Bastianetto, S., Ramassamy, C., Poirier, J., & Quirion, R. (1999). Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Research and Molecular Brain Research, 20, 35-41.
6. Bonnefoy, M., Kostka, T., Patricot, M. C., Berthouse, S. E., Mathian, B., & Lacour, J. R. (1998). Physical activity and dehydroepiandrosterone sulfate, insulin-like growth factor I and testosterone in healthy active elderly people. Age and Ageing, 27, 745-751.
7. Carlson, L. E., Sherwin, B. B., & Cherktkow, H. M. (1999). Relationship between dehydroepiandrosterone-sulfate (DHEAS) and cortisol (CRT), and everyday memory in Alzheimer's disease patients compared to healthy controls. Hormones and Behavior, 35, 254-263.
8. Cruess, D. G., Antoni, M. H., Kumar, M., Ironson, G., McCabe, P., Femandez, J. B., Fletcher, M., & Schneiderman, N. (1999). Cognitive-behavioral stress management buffers decreases in dehydroepiandrosterone sulfate (DHEA-S) and increases in the cortisol/DHEA-S ratio and reduces mood disturbance and perceived stress among HIV-seropositive men. Psychoneuroendocrinology, 24, 537-549.
9. Cuckle, H., Stone, R., Smith, D., Wald, N., Brammer, M., Hajimohammedreza, I., Levy, R., Chard, T., & Perry, I. (1990). Dehydroepiandrosterone sulfate in Alzheimer's disease. The Lancet (Letter), 336, 449-450.
10. De Leon, M. J., McRae, T., Rusinek, H., Convit, A., De Santi, S., Tarshish, C., Golomb, J., Volkow, N., Daisley, K., Orentreich, N., & McEwen, B. (1997). Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease. Journal of Clinical Endocrinology and Metabolism, 82, 3251-3259.
11. Folstein, M., Folstein, S., & McHugh, P. S. (1975). Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
12. Frye, C. A., & Lacey, E. H. (1999). The neurosteroids DHEA and DHEAS may influence cognitive performance by altering affective state. Physiology and Behavior, 66, 85-92.
13. Guazzo, E. P., Kirkpatrick, P. J., Goodyer, I. M., Shiers, H. M., & Herbert, J. (1997). Cortisol, dehydroepiandrosterone (DHEA) and DHEA sulfate in the cerebrospinal fluid of man: Relation to blood levels and the effects of age. Journal of Clinical Endocrinology and Metabolism, 81, 3951-3960.
14. Herndon, J. G., Lacreuse, A., Ladinsky, E., Killiany, R. J., Rosene, D. L., & Moss, M. B. (1999). Age-related decline in DHEAS is not related to cognitive impairment in aged monkeys. Neuroreport, 10, 3507-3511.
15. Kalmijn, S., Launer, L. J., Stolk, R. P., de Jong, F. H., Pols, H. P., Hofman, A., Breteler, M. M. B., & Lamberts, S. W. J. (1998). A prospective study of cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly. Journal of Clinical Endocrinology and Metabolism, 83, 3487-3492.
16. Leblhuber, F., Neubauer, C., Peichl, M., Reisecker, F., Steinparz, F. X., Windhager, E., & Dienstl, E. (1993). Age and sex differences of dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT plasma levels in normal controls and Alzheimer's disease (AD). Psychopharmacology, 111, 23-26.
17. Legrain, S., Berr, C., Frenoy, N., Gourlet, V., Debuire, B., & Baulieu, E. E. (1995). Dehydroepiandrosterone sulfate in a long-term care aged population. Gerontology, 41, 343-351.
18. Maccario, M., Mazza, E., Ramunni, J., Oleandri, S. E., Savio, P., Grottoli, S., Rossetto, R., Procopio, M., Gauna, C., & Ghigo, E. (1999). Relationships between dehydroepiandrosterone-sulfate and anthropometric, metabolic and hormonal variables in a large cohort of obese women. Clinical Endocrinology, 50, 595-600.
19. Magri, F., Terenzi, F., Ricciardi, T., Fioravanti, M., Solerte, S. B., Stabile, M., Balza, G., Gandini, C., & Villa, M. (2000). Association between changes in adrenal secretion and cerebral morphometric correlates in normal aging and senile dementia. Dementia and Geriatric Cognitive Disorders, 11, 90-99.
20. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Alzheimer's disease. Neurology, 34, 939-944.
21. Miller, T. P., Taylor, J., Rogerson, S., Mauricio, M., Kennedy, Q., Schatzberg, A., Tinklenberg, J., & Yesavage, J. (1998). Cognitive and non-cognitive symptoms in dementia patients: Relationship to cortisol and dehydroepiandrosterone. International Psychogeriatrics, 10, 85-96.
22. Morrison, F., Redei, E., TenHave, T., Parmelee, P., Boyce, A. A., Sinha, P. S., & Katz, I. R. (2000). Dehydroepiandrosterone sulfate and psychiatric measures in a frail, elderly residential care population. Biological Psychiatry, 47, 144-150.
23. Ng, H. P., Wang, Y. F., Lee, C. Y., & Hu, H. L. (1999). Toxicological and antioxidant effects of short-term dehydroepiandrosterone injection in young rats fed diets deficient or adequate in vitamin E. Food and Chemical Toxicology, 37, 503-508.
24. O'Brien, J. T., Ames, D., Schweitzer, I., Colman, P., Desmon, P., & Tress, B. (1996a). Clinical and magnetic resonance imaging correlates of hypathalamic-pituitary-adrenal axis function in depressed and Alzheimer's disease. British Journal of Psychiatry, 168, 679-687.
25. O'Brien, J. T., Ames, D., Schweitzer, I., Mastwyk, M., & Colman, P. (1996b). Enhanced adrenal sensitivity to adrenocorticotrophic hormone (ACTH) is evidence of HPA axis hyperactivity in Alzheimer's disease. Pschological Medicine, 26, 7-14.
26. Parker, C. R. (1999). Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in the human adrenal during development and aging. Steroids, 64, 640-647.
27. Petrie, B. C., Wilkinson, C. W., Murray, S., Jensen, C., Peskind, E. R., & Raskind, M. A. (1999). Effects of Alzheimer's disease and gender on the hypothalamic-pituitary-adrenal axis response to lumbar puncture stress. Psychoneuroendocrinology, 24, 385-395.
28. Rasmuson, S., Nasman, B., Erickson, S., Carlstrom, K., & Olsson, T. (1998). Adrenal responsivity in normal aging and mild to moderate Alzheimer's disease. Biological Psychiatry, 43, 401-407.
29. Rudman, D., Shetty, K. R., & Mattson, D. E. (1990). Plasma dehydroepiandrosterone sulfate in nursing home men. Journal of American Geriatric Society, 50, 421-427.
30. Ruprecht, R., & Holsboer, F. (1999). Neuropsychopharmacological properties of neuroactive steroids. Steroids, 64, 83-91.
31. Solerte, S. B., Cerutti, N., Severgnini, S., Rondanelli, M., Ferrari, E., & Fioravanti, M. (1998). Decreased immunosupressive effect of cortisol on natural killer cytotoxic activity in senile dementia of the Alzheimer type. Dementia Geriatric and Cognitive Disorders, 9, 149-156.
32. Spath-Scwalbe, E., Dodt, C., Dittmann, J., Schuttler, R., & Fehm, H. L. (1990). Dehydroepiandrosterone sulfate in Alzheimer's disease. The Lancet, 335, 1412.
33. Sunderland, T., Merril, C. R., & Harrington, M. G. (1989). Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease. The Lancet II, 570.
34. Svec, F. (1997). Ageing and adrenal cortical function. Baillieres Clinical Endocrinology and Metabolism, 11, 271-287.
35. Swanwick, G. R., Kirby, M., Bruce, I., Buggy, F., Coen, R. F., Coakley, D., & Lawlor, B. A. (1998). Hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease: Lack of association between longitudinal and cross-sectional findings. American Journal of Psychiatry, 155, 286-299.
36. Thomas, N., Morris, H., Scopacasa, F., Wishart, J. M., & Need, G. (1999). Relationships between age, dehydroepiandrosterone sulfate and plasma glucose in healthy men. Age and Ageing, 28, 217-220.
37. Tilvis, R. S., Kahonen, M., & Harkonen, M. (1999). Dehydroepiandrosterone sulfate, diseases and mortality in a general aged population. Aging, 11, 30-34.
38. Watson, R. R., Huls, D., Araghinikuam, M., & Chung, S. (1996). Dehydroepiandrosterone and diseases of aging. Drugs and Aging, 9, 274-291.
39. Wolf, O. T., Neumann, O., Hellmanner, D. H., Geiben, A. C., Strasburger, C. J., Dressendorfer, R. A., Pirke, K. M., & Kirchbaum, C. (1997). Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. Journal of Clinical Endocrinology and Metabolism, 82, 2363-2367.
40. Wolf, O. T., Neumann, O., Hellmanner, D. H., & Kirchbaum, C. (1998). Effects of dehydroepiandrosterone replacement in elderly men on event-related brain potentials, memory and well-being. Journal of Gerontology, 5, 385-390.
41. Wolf, O. T., & Kirchbaum, C. (1999). Actions of dehydroepiandrosterone and its sulfate in the central nervous system effects on cognition and emotion in animals and humans. Brain Research and Brain Research Reviews, 3, 264-288.
42. Yaffe, K., Ettinger, B., Pressman, A., Seeley, D., Whooley, M., Schaefer, C., & Cummings, S. (1998). Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: A prospective study. Biological Psychiatry, 4, 694-700.
43. Yaffe, K., Browner, W., Cauley, J., Launer, L., & Harris, T. (1999). Association between bone mineral density and cognitive decline in older women. Journal of the American Geriatrics Society, 47, 1176-1182.
44. Zwain, I. H., & Yen, S. S. (1999). Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology, 140, 3843-3852.